Showing results (261-270 of 4,036) with videos related to

Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|August 20, 2019
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactionsGiulia Bonaldo, Luisa Anna Andriani, Ottavio D'Annibali, et al.
Pharmacoepidemiology and Drug Safety|September 12, 2019
L-TRUST: Long-term risk of cancer in patients under statins therapy. A systematic review and meta-analysisNuno Sales Craveiro, Bruno Silva Lopes, Lara Tomás, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2019
Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in childrenMaja Markovic, Sonja A Swanson, Bruno H Stricker, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2019
Secret safety warnings on medicines: A case study of information access requestsMarc Torka, Barbara Mintzes, Alice Bhasale, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomesFrancesco Cottone, Amelie Anota, Franck Bonnetain, et al.
Pharmacoepidemiology and Drug Safety|February 21, 2019
Quantifying bias reduction with fixed-duration versus all-available covariate assessment periodsJohn G Connolly, Sebastian Schneeweiss, Robert J Glynn, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2021
Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processingJialin Mao, Art Sedrakyan, Tianyi Sun, et al.
Pharmacoepidemiology and Drug Safety|November 10, 2021
Nonsteroidal anti-inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta-analysisJun Gong, Lingyue Ma, Mengya Li, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2019
Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patientsHanna E Tervonen, Benjamin Daniels, Monica Tang, et al.
Pharmacoepidemiology and Drug Safety|March 16, 2019
An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records databaseGillis Carrigan, Samuel Whipple, Michael D Taylor, et al.
Pageof 404